Clinical course of herpes virus skin diseases on the background of HIV

Authors

DOI:

https://doi.org/10.26641/2307-0404.2022.2.260287

Keywords:

human immunodeficiency virus, herpes virus skin diseases, clinical course, melatonin

Abstract

Dermatological diseases are widespread among the HIV-infected population. Due to the continuing increase in the incidence of HIV, skin manifestations are becoming more common, especially herpes virus infections. Many of them are not unique in this group but the disease may not be typical, severe and systemic, which always complicates the diagnosis. Many studies demonstrate the specifics of the clinical course of HIV, in particular opportunistic infections, but a separate syste­matization of herpetic manifestations of HIV has not been conducted to date. On the other hand, the introduction of highly active antiretroviral therapy has been accompanied by some reduction in skin manifestations associated with HIV, and for clinicians the low efficacy of acyclovir in this category of patients, remains the main problem and therefore requires new approaches. The aim of this article was to study and compare the clinical course of herpes virus skin diseases on the background of HIV, taking into account the severity and stage of the underlying disease, based on the international classification of HIV adopted by the Centers for Disease Control (CDC). From September, 2018 to October, 2020, herpes was studied in 59 HIV patients and it was found that the nature of dermatological manifestations of herpes virus infections depends on the level of CD4+ cells. To expand drug provision, treat comorbid conditions and improve the quality of life of each patient, the dissertation, research «Clinical and immunological significance of IL-31 and melatonin in herpes virus skin diseases on the background of HIV infection and methods of their correction» is planned.

References

[Statistics on the prevalence of human immunodeficiency virus (HIV) in Ukraine (according to the Center for Public Health of the Ministry of Health of Ukraine, 2020)]. 2020. Available from: https://phc.org.ua/news/statistika-vil-i-tb-v-ukraini-listopad-2020-roku

Bender Ignacio RA, Ramchandani MS. T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recur-rences. Viral Immunol. 2017 Jan 1;30(1):77-80. doi: https://doi.org/10.1089/vim.2016.0097

Burrel S, Topalis D, Boutolleau D. Herpes simplex virus resistance to antivirals. Virologie (Montrouge). 2020 Oct 1;24(5):325-42. doi: https://doi.org/10.1684/vir.2020.0864

Chelidze K, Thomas C, Chang AY, Freeman EE. HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management. Am J Clin Dermatol. 2019 Jun;20(3):423-42. doi: https://doi.org/10.1007/s40257-019-00422-0

Li YY, Yang SH, Wang RR, Tang JT, Wang HM, Kuang YQ. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China. Int J Dermatol. 2020 Mar;59(3):308-13. doi: https://doi.org/10.1111/ijd.14725

Mirnezami М, Zarinfar N, Sofian М, Yadegar BB, Rahimi H. Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts. Scientifica (Cairo). 2020 Aug 11;2020:7503756. doi: https://doi.org/10.1155/2020/7503756

Munawwar A, Singh S. Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians. 2016 Jan-Jun;8(1):5-18. doi: https://doi.org/10.4103/0974-2727.176228

James C, Harfouche M, Welton NJ, Turner KME, Abu-Raddad LJ, Gottlieb SL, Looker KJ. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315-29. doi: https://doi.org/10.2471/BLT.19.237149

Sarah J Coates, Kieron S Leslie. What's new in HIV dermatology? Version 1. F1000Res. 2019;8:886. doi: https://doi.org/10.12688/f1000research.16182.1

Simões Quaresma JA. Organization of the Skin Immune System and Compartmentalized Immune Responses in Infectious Diseases. Clin Microbiol Rev. 2019 Jul 31;32(4):e00034-18. doi: https://doi.org/10.1128/CMR.00034-18

Vigil KJ, Salazar L, Hasbun R. Community-Acquired Meningitis in HIV-Infected Patients in the United States. AIDS Patient Care STDS. 2018 Feb;32(2):42-47. doi: https://doi.org/10.1089/apc.2017.0286

Vockerodt M, Yap LF, Shannon-Lowe C, Cur-ley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J. Pathol. 2015;235:312-22. doi: https://doi.org/10.1002/path.4459

Hanusz Z, Joanna Tarasinska J, Zielinski W. Sha-piro-Wilk test with known mean. REVSTAT. Statistical Journal. 2016;14(1):89-100.

Pérez N, López M, Silva A, Ramos I. Improving the Mann–Whitney statistical test for feature selection: An approach in breast cancer diagnosis on mammography. Artificial Intelligence in Medicine. 2015;63(1):19-31. doi: https://doi.org/10.1016/j.artmed.2014.12.004

Abbas FM Alkarkhi, Wasin AA Alqaraghuli. Discriminant Analysis and Classification, Easy Statistics for Science with R, Ch. 10. Academic Press. 2019:161-75. doi: https://doi.org/10.1016/B978-0-12-814262-2.00010-8

Published

2022-06-28

How to Cite

1.
Liadova T, Dorosh D, Volobuieva O, Popov М, Martynenko O, Kadyhrob I, Sorokina O. Clinical course of herpes virus skin diseases on the background of HIV. Med. perspekt. [Internet]. 2022Jun.28 [cited 2024Mar.29];27(2):131-8. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/260287

Issue

Section

CLINICAL MEDICINE